BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 19, Issue 40
This Article
Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (13725)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.
Item 
Count 
PDF1322
HTML12070
Figures (1-2)206
Tables (1-1)127
 Sum=13725
Oct 28, 2013 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Ma YY, Li L, Yu CH, Shen Z, Chen LH, Li YM. Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis. World J Gastroenterol 2013; 19(40): 6911-6918 [PMID: 24187469 DOI: 10.3748/wjg.v19.i40.6911]
URL: https://www.wjgnet.com/1007-9327/full/v19/i40/6911.htm
Number Citing Articles
1
Brian A. Nadeau, Hari Conjeevaram. The gut microbiome and nonalcoholic fatty liver disease. Clinical Liver Disease 2017; 10(5): 116 doi: 10.1002/cld.671
2
Surender Jangra, Ramesh Pothuraju. Microbial Diversity, Interventions and Scope. 2020; : 321 doi: 10.1007/978-981-15-4099-8_18
3
Kareem Hassan, Varun Bhalla, Mohammed Ezz El Regal, H Hesham A-Kader. Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic. World Journal of Gastroenterology 2014; 20(34): 12082-12101 doi: 10.3748/wjg.v20.i34.12082
4
Salvatore Pezzino, Maria Sofia, Gloria Faletra, Chiara Mazzone, Giorgia Litrico, Gaetano La Greca, Saverio Latteri. Gut–Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome. Biology 2022; 11(11): 1622 doi: 10.3390/biology11111622
5
Neerja Hajela, B. S. Ramakrishna, G. Balakrish Nair, Philip Abraham, Sarath Gopalan, Nirmal K. Ganguly. Gut microbiome, gut function, and probiotics: Implications for health. Indian Journal of Gastroenterology 2015; 34(2): 93 doi: 10.1007/s12664-015-0547-6
6
Stavros Bashiardes, Hagit Shapiro, Shachar Rozin, Oren Shibolet, Eran Elinav. Non-alcoholic fatty liver and the gut microbiota. Molecular Metabolism 2016; 5(9): 782 doi: 10.1016/j.molmet.2016.06.003
7
Claudio Hidalgo-Cantabrana, Susana Delgado, Lorena Ruiz, Patricia Ruas-Madiedo, Borja Sánchez, Abelardo Margolles. Bugs as Drugs. 2018; : 73 doi: 10.1128/9781555819705.ch3
8
Rohan Dalal, Richard G McGee, Stephen M Riordan, Angela C Webster. Probiotics for people with hepatic encephalopathy. Cochrane Database of Systematic Reviews 2017; 2021(1) doi: 10.1002/14651858.CD008716.pub3
9
Yong Kyun Cho. Combination of synbiotic and sitagliptin in nonalcoholic fatty liver disease: Is it better than sitagliptin alone?. Clinical and Molecular Hepatology 2018; 24(3): 299 doi: 10.3350/cmh.2018.1006
10
Muhammad Y. Khan, Albana B. Mihali, Muhammad S. Rawala, Aysha Aslam, Waqas J. Siddiqui. The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease – a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2019; 31(6): 703 doi: 10.1097/MEG.0000000000001371
11
Noreen Neuwirth, Samuel Kochenburger, Christian Sina. Mikrobiom und metabolische Fettlebererkrankung (MeFLD). Der Diabetologe 2021; 17(4): 391 doi: 10.1007/s11428-021-00725-z
12
Concetta Mastromauro, Nella Polidori, Cosimo Giannini. Metabolic dysfunction-associated fatty liver disease in obese youth with insulin resistance and type 2 diabetes. Current Opinion in Pediatrics 2022; 34(4): 414 doi: 10.1097/MOP.0000000000001138
13
Zhenghao Pan, Bingyong Mao, Qiuxiang Zhang, Xin Tang, Bo Yang, Jianxin Zhao, Shumao Cui, Hao Zhang. Postbiotics Prepared Using Lactobacillus paracasei CCFM1224 Prevent Nonalcoholic Fatty Liver Disease by Modulating the Gut Microbiota and Liver Metabolism. International Journal of Molecular Sciences 2022; 23(21): 13522 doi: 10.3390/ijms232113522
14
Hanzhi Xu, Xun Qiu, Zhoucheng Wang, Kai Wang, Yawen Tan, Fengqiang Gao, Marcos Vinicius Perini, Xiao Xu. Role of the portal system in liver regeneration: From molecular mechanisms to clinical management. Liver Research 2024; 8(1): 1 doi: 10.1016/j.livres.2024.01.002
15
Maria Grazia Clemente, Claudia Mandato, Marco Poeta, Pietro Vajro. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions. World Journal of Gastroenterology 2016; 22(36): 8078-8093 doi: 10.3748/wjg.v22.i36.8078
16
Ibrahim G. Saleh, Zulfiqar Ali, Naohito Abe, Farid M. Hamada, Mohamed F. Abd-Ellah, Larry A. Walker, Ikhlas A. Khan, Mohammad K. Ashfaq. Possible hepatocellular toxicity of EGCG under the influence of an inflammagen. Journal of Applied Biomedicine 2014; 12(4): 291 doi: 10.1016/j.jab.2014.03.001
17
C. Punzalan, A. Qamar. The Microbiota in Gastrointestinal Pathophysiology. 2017; : 373 doi: 10.1016/B978-0-12-804024-9.00040-9
18
Cat. Buffet, Cam. Buffet. Les hépatopathies stéatosiques non alcooliques et le microbiote intestinal. Médecine des Maladies Métaboliques 2015; 9(3): 301 doi: 10.1016/S1957-2557(15)30078-X
19
Pramodini Kale-Pradhan, Sheila Wilhelm. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 19th Edition. 2017;  doi: 10.21019/9781582122656.ch20
20
Ali Abdul-Hai, Ali Abdallah, Stephen DH Malnick. Influence of gut bacteria on development and progression of non-alcoholic fatty liver disease. World Journal of Hepatology 2015; 7(12): 1679-1684 doi: 10.4254/wjh.v7.i12.1679
21
Jun-Ling Han, Hui-Ling Lin. Intestinal microbiota and type 2 diabetes: From mechanism insights to therapeutic perspective. World Journal of Gastroenterology 2014; 20(47): 17737-17745 doi: 10.3748/wjg.v20.i47.17737
22
Silvia Ferolla, Geyza Armiliato, Cláudia Couto, Teresa Ferrari. The Role of Intestinal Bacteria Overgrowth in Obesity-Related Nonalcoholic Fatty Liver Disease. Nutrients 2014; 6(12): 5583 doi: 10.3390/nu6125583
23
Winda P. Bastian, Irsan Hasan, C. Rinaldi A. Lesmana, Ikhwan Rinaldi, Rino A. Gani. Gut Microbiota Profiles in Nonalcoholic Fatty Liver Disease and Its Possible Impact on Disease Progression Evaluated with Transient Elastography: Lesson Learnt from 60 Cases. Case Reports in Gastroenterology 2019; 13(1): 125 doi: 10.1159/000498946
24
Qiwei Shi, Lingli Dai, Qi Zhao, Xian Zhang. A review on the effect of gut microbiota on metabolic diseases. Archives of Microbiology 2022; 204(3) doi: 10.1007/s00203-022-02802-3
25
Zhe Zhang, Hui Zhou, Xiaohong Zhou, Jize Sun, Xi Liang, Youyou Lv, Lu Bai, Junxue Zhang, Pimin Gong, Tongjie Liu, Huaxi Yi, Jingfeng Wang, Lanwei Zhang. Lactobacillus casei YRL577 ameliorates markers of non-alcoholic fatty liver and alters expression of genes within the intestinal bile acid pathway. British Journal of Nutrition 2021; 125(5): 521 doi: 10.1017/S0007114520003001
26
Newaz Hossain, Pushpjeet Kanwar, Smruti R. Mohanty. A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD. Gastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/7109270
27
Giulia Paolella, Claudia Mandato, Luca Pierri, Marco Poeta, Martina Di Stasi, Pietro Vajro. Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease. World Journal of Gastroenterology 2014; 20(42): 15518-15531 doi: 10.3748/wjg.v20.i42.15518
28
Anne Sophie Schneck, Rodolphe Anty, Albert Tran, Audrey Hastier, Imed Ben Amor, Jean Gugenheim, Antonio Iannelli, Thierry Piche. Increased Prevalence of Irritable Bowel Syndrome in a Cohort of French Morbidly Obese Patients Candidate for Bariatric Surgery. Obesity Surgery 2016; 26(7): 1525 doi: 10.1007/s11695-015-1907-0
29
Hannele Yki‐Järvinen. Clinical Dilemmas in Non‐Alcoholic Fatty Liver Disease. 2016; : 189 doi: 10.1002/9781118924938.ch21
30
Sukrit Kanchanasurakit, Chayanis Kositamongkol, Kamonnat Lanoi, Monnaree Nunta, Thaksaporn Saetuan, Nathorn Chaiyakunapruk, Surasak Saokaew, Pochamana Phisalprapa. Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.880014
31
Vanessa Stadlbauer-Köllner. Probiotika bei Lebererkrankungen. Wiener klinisches Magazin 2018; 21(6): 240 doi: 10.1007/s00740-018-0250-1
32
Winston Hernández-Ceballos, Jacqueline Cordova-Gallardo, Nahum Mendez-Sanchez. Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2020.00131
33
Thomas M. Barber, Petra Hanson, Martin O. Weickert. Metabolic-Associated Fatty Liver Disease and the Gut Microbiota. Endocrinology and Metabolism Clinics of North America 2023; 52(3): 485 doi: 10.1016/j.ecl.2023.01.004
34
Diptadip Dattaroy, Ratanesh Kumar Seth, Suvarthi Das, Firas Alhasson, Varun Chandrashekaran, Gregory Michelotti, Daping Fan, Mitzi Nagarkatti, Prakash Nagarkatti, Anna Mae Diehl, Saurabh Chatterjee. Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activation. American Journal of Physiology-Gastrointestinal and Liver Physiology 2016; 310(7): G510 doi: 10.1152/ajpgi.00259.2015
35
Hyeonji Kim, Kippeum Lee, Ju-Yeon Kim, Jae-Jung Shim, Junghyun Lim, Joo-Yun Kim, Jung-Lyoul Lee. Lactobacillus helveticus Isolated from Raw Milk Improves Liver Function, Hepatic Steatosis, and Lipid Metabolism in Non-Alcoholic Fatty Liver Disease Mouse Model. Microorganisms 2023; 11(10): 2466 doi: 10.3390/microorganisms11102466
36
Qingqing Zhang, Yucheng Wu, Xiaoqiang Fei. Effect of probiotics on body weight and body-mass index: a systematic review and meta-analysis of randomized, controlled trials. International Journal of Food Sciences and Nutrition 2016; 67(5): 571 doi: 10.1080/09637486.2016.1181156
37
S. Fine, C.R. Kelly. The Microbiota in Gastrointestinal Pathophysiology. 2017; : 315 doi: 10.1016/B978-0-12-804024-9.00034-3
38
Niloufar Rasaei, Mohammadreza Heidari, Fataneh Esmaeili, Sepehr Khosravi, Maryam Baeeri, Ozra Tabatabaei-Malazy, Solaleh Emamgholipour. The effects of prebiotic, probiotic or synbiotic supplementation on overweight/obesity indicators: an umbrella review of the trials’ meta-analyses. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1277921
39
J. P. Ong, Z. M. Younossi. Editorial: probiotics in NASH – more studies are needed. Alimentary Pharmacology & Therapeutics 2014; 40(2): 211 doi: 10.1111/apt.12812
40
Saumya Jayakumar, Rohit Loomba. Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications. Alimentary Pharmacology & Therapeutics 2019; 50(2): 144 doi: 10.1111/apt.15314
41
Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, Marjo Campmans-Kuijpers, Vincenzo Cardinale, Irit Chermesh, Ahad Eshraghian, Haluk Tarik Kani, Wafaa Khannoussi, Laurence Lacaze, Miguel Léon-Sanz, Juan M. Mendive, Michael W. Müller, Johann Ockenga, Frank Tacke, Anders Thorell, Darija Vranesic Bender, Arved Weimann, Cristina Cuerda. European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guideline. Clinical Nutrition 2022; 41(10): 2364 doi: 10.1016/j.clnu.2022.07.003
42
Frank Tacke, Ralf Weiskirchen. An update on the recent advances in antifibrotic therapy. Expert Review of Gastroenterology & Hepatology 2018; 12(11): 1143 doi: 10.1080/17474124.2018.1530110
43
Liang Liu, Ping Li, Yiqi Liu, Yilian Zhang. Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-Analysis. Digestive Diseases and Sciences 2019; 64(12): 3402 doi: 10.1007/s10620-019-05699-z
44
M.A. Valdovinos, E. Montijo, A.T. Abreu, S. Heller, A. González-Garay, D. Bacarreza, M. Bielsa-Fernández, M.C. Bojórquez-Ramos, F. Bosques-Padilla, A.I. Burguete-García, R. Carmona-Sánchez, A. Consuelo-Sánchez, E. Coss-Adame, J.A. Chávez-Barrera, M. de Ariño, J. Flores-Calderón, O. Gómez-Escudero, M.S. González-Huezo, M.E. Icaza-Chávez, A. Larrosa-Haro, M. Morales-Arámbula, C. Murata, J.A. Ramírez-Mayans, J.M. Remes-Troche, T. Rizo-Robles, M. Peláez-Luna, E.M. Toro-Monjaraz, A. Torre, M.E. Urquidi-Rivera, R. Vázquez, J.K. Yamamoto-Furusho, F. Guarner. Consenso mexicano sobre probióticos en gastroenterología. Revista de Gastroenterología de México 2017; 82(2): 156 doi: 10.1016/j.rgmx.2016.08.004
45
Floriana Elvira Ionică, Simona Negreș, Ludovic Bejenaru, Cornelia Bejenaru, Cornel Chiriță. Pharmacological Approaches for Nonalcoholic Fatty Liver Disease. Romanian Journal of Diabetes Nutrition and Metabolic Diseases 2016; 23(3) doi: 10.1515/rjdnmd-2016-0037
46
İhsan Boyacı, Süleyman Yıldırım. Metabolik Sendrom Tedavisinde Bağırsak Mikrobiyotasının Probiyotikler ve Özelinde Saccharomyces Boulardii ile Modülasyonu. Anadolu Kliniği Tıp Bilimleri Dergisi 2017;  doi: 10.21673/anadoluklin.260702
47
Brandon Perumpail, Andrew Li, Nimy John, Sandy Sallam, Neha Shah, Waiyee Kwong, George Cholankeril, Donghee Kim, Aijaz Ahmed. The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD. Diseases 2019; 7(1): 27 doi: 10.3390/diseases7010027
48
Louis H. S. Lau, Sunny H. Wong. Obesity, Fatty Liver and Liver Cancer. Advances in Experimental Medicine and Biology 2018; 1061: 111 doi: 10.1007/978-981-10-8684-7_9
49
Nathalie Michels, Semi Zouiouich, Bert Vanderbauwhede, Judith Vanacker, B. Iciar Indave Ruiz, Inge Huybrechts. Human microbiome and metabolic health: An overview of systematic reviews. Obesity Reviews 2022; 23(4) doi: 10.1111/obr.13409
50
M.A. Valdovinos, E. Montijo, A.T. Abreu, S. Heller, A. González-Garay, D. Bacarreza, M. Bielsa-Fernández, M.C. Bojórquez-Ramos, F. Bosques-Padilla, A.I. Burguete-García, R. Carmona-Sánchez, A. Consuelo-Sánchez, E. Coss-Adame, J.A. Chávez-Barrera, M. de Ariño, J. Flores-Calderón, O. Gómez-Escudero, M.S. González-Huezo, M.E. Icaza-Chávez, A. Larrosa-Haro, M. Morales-Arámbula, C. Murata, J.A. Ramírez-Mayans, J.M. Remes-Troche, T. Rizo-Robles, M. Peláez-Luna, E.M. Toro-Monjaraz, A. Torre, M.E. Urquidi-Rivera, R. Vázquez, J.K. Yamamoto-Furusho, F. Guarner. The Mexican consensus on probiotics in gastroenterology. Revista de Gastroenterología de México (English Edition) 2017; 82(2): 156 doi: 10.1016/j.rgmxen.2017.03.003
51
Reiner Wiest, Agustin Albillos, Michael Trauner, Jasmohan S. Bajaj, Rajiv Jalan. Targeting the gut-liver axis in liver disease. Journal of Hepatology 2017; 67(5): 1084 doi: 10.1016/j.jhep.2017.05.007
52
Claudio Hidalgo-Cantabrana, Susana Delgado, Lorena Ruiz, Patricia Ruas-Madiedo, Borja Sánchez, Abelardo Margolles, Robert Allen Britton, Patrice D. Cani. Bifidobacteria and Their Health-Promoting Effects. Microbiology Spectrum 2017; 5(3) doi: 10.1128/microbiolspec.BAD-0010-2016
53
Tetyana Falalyeyeva, Nazarii Kobyliak, Oleksandr Korotkyi, Tamara Meleshko, Oksana Sulaieva, Iryna Hryshchenko, Liudmyla Domylivska, Nadiya Boyko. Microbiome in 3P Medicine Strategies. Advances in Predictive, Preventive and Personalised Medicine 2023; 16: 101 doi: 10.1007/978-3-031-19564-8_5
54
Nikita Khanna, Priyanka Devi, Anil Kumar, Sandip V. Pawar. Probiotic Research in Therapeutics. 2021; : 335 doi: 10.1007/978-981-33-6236-9_15
55
Atefe Asgharian, Vida Mohammadi, Zahra Gholi, Ahmad Esmaillzade, Awat Feizi, Gholamreza Askari. The Effect of Synbiotic Supplementation on Body Composition and Lipid Profile in Patients with NAFLD: A Randomized, Double Blind, Placebo-Controlled Clinical Trial Study. Iranian Red Crescent Medical Journal 2017; 19(4) doi: 10.5812/ircmj.42902
56
Carmen Lara Romero, Lucía López Bermudo, Miguel Fernández Gómez, Andrea Cornejo, Genoveva Berná, Manuel Romero-Gómez. Comprehensive Guide to Hepatitis Advances. 2023; : 343 doi: 10.1016/B978-0-323-98368-6.00019-7
57
Jin-Jin Dai, Ya-Fei Zhang, Zhen-Hua Zhang. Global trends and hotspots of treatment for nonalcoholic fatty liver disease: A bibliometric and visualization analysis (2010-2023). World Journal of Gastroenterology 2023; 29(37): 5339-5360 doi: 10.3748/wjg.v29.i37.5339
58
Grace Hatton, Tommaso Alterio, Valerio Nobili, Jake P. Mann. Unmet needs in pediatric NAFLD research: what do we need to prioritize for the future?. Expert Review of Gastroenterology & Hepatology 2018; 12(10): 961 doi: 10.1080/17474124.2018.1512853
59
Boyeon Kim, Bukyung Kim. Gut microbiota and nonalcoholic fatty liver disease . Kosin Medical Journal 2023; 38(3): 169 doi: 10.7180/kmj.23.138
60
Beng San Yeoh, Matam Vijay-Kumar. Mechanisms Underlying Host-Microbiome Interactions in Pathophysiology of Human Diseases. 2018; : 129 doi: 10.1007/978-1-4939-7534-1_7
61
Jag Khalsa, Linda C. Duffy, Gabriela Riscuta, Pamela Starke‐Reed, Van S. Hubbard. Omics for Understanding the Gut‐Liver‐Microbiome Axis and Precision Medicine. Clinical Pharmacology in Drug Development 2017; 6(2): 176 doi: 10.1002/cpdd.310
62
Michelle L. Dossett, Ezra M. Cohen, Jonah Cohen. Integrative Medicine for Gastrointestinal Disease. Primary Care: Clinics in Office Practice 2017; 44(2): 265 doi: 10.1016/j.pop.2017.02.002
63
Mariangela Rondanelli, Milena Anna Faliva, Simone Perna, Attilio Giacosa, Gabriella Peroni, Anna Maria Castellazzi. Using probiotics in clinical practice: Where are we now? A review of existing meta-analyses. Gut Microbes 2017; 8(6): 521 doi: 10.1080/19490976.2017.1345414
64
Cyriac Abby Philips, Philip Augustine, Praveen Kumar Yerol, Ganesh Narayan Ramesh, Rizwan Ahamed, Sasidharan Rajesh, Tom George, Sandeep Kumbar. Modulating the Intestinal Microbiota: Therapeutic Opportunities in Liver Disease. Journal of Clinical and Translational Hepatology 2019; (X): 1 doi: 10.14218/JCTH.2019.00035
65
Gokulapriya Ramachandran, Biju Pottakkat. Probiotics—A Promising Novel Therapeutic Approach in the Management of Chronic Liver Diseases. Journal of Medicinal Food 2024;  doi: 10.1089/jmf.2023.K.0129
66
Rosângela Passos de Jesus, Naiara Brunelle Oliveira Neiva, Thomas Thássio Rodrigues de Araújo Silva. A síndrome metabólica e suas implicações clínicas. 2018; : 139 doi: 10.7476/9786588211113.0007
67
György M. Buzás. Helicobacter pylori and non-alcoholic fatty liver disease. Minerva Gastroenterologica e Dietologica 2020; 66(3) doi: 10.23736/S1121-421X.20.02671-9
68
Alessandro Federico, Claudio Zulli, Ilario de Sio, Anna Del Prete, Marcello Dallio, Mario Masarone, Carmela Loguercio. Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease. World Journal of Gastroenterology 2014; 20(45): 16841-16857 doi: 10.3748/wjg.v20.i45.16841
69
Masami Minemura, Yukihiro Shimizu. Gut microbiota and liver diseases. World Journal of Gastroenterology 2015; 21(6): 1691-1702 doi: 10.3748/wjg.v21.i6.1691
70
Veronika A. Prikhodko, Natalia N. Bezborodkina, Sergey V. Okovityi. Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates. Biomedicines 2022; 10(2): 274 doi: 10.3390/biomedicines10020274
71
Abdolmajid Ghasemian, Majid Eslami, Morvarid Shafiei, Sohrab Najafipour, Ali Rajabi. Probiotics and their increasing importance in human health and infection control. Reviews in Medical Microbiology 2018; 29(4): 153 doi: 10.1097/MRM.0000000000000147
72
José Tadeu Stefano, Sebastião Mauro Bezerra Duarte, Renato Gama Ribeiro Leite Altikes, Claudia P. Oliveira. Non-pharmacological management options for MAFLD: a practical guide. Therapeutic Advances in Endocrinology and Metabolism 2023; 14: 204201882311603 doi: 10.1177/20420188231160394
73
Claudia Della Corte, Pietro Vajro, Piotr Socha, Valerio Nobili. Pediatric non-alcoholic fatty liver disease: Recent advances. Clinics and Research in Hepatology and Gastroenterology 2014; 38(4): 419 doi: 10.1016/j.clinre.2014.02.008
74
Amanda Chaney. Treating the patient with nonalcoholic fatty liver disease. The Nurse Practitioner 2015; 40(11): 36 doi: 10.1097/01.NPR.0000472248.28703.18
75
Gina P. Rodriguez-Castaño, Alejandro Caro-Quintero, Alejandro Reyes, Fernando Lizcano. Advances in Gut Microbiome Research, Opening New Strategies to Cope with a Western Lifestyle. Frontiers in Genetics 2017; 7 doi: 10.3389/fgene.2016.00224
76
Tejaswini Baral, Shilia Jacob Kurian, Sonal Sekhar M., Murali Munisamy, Chandrashekar Udyavara Kudru, Bidita Khandelwal, Mithu Banerjee, Chiranjay Mukhopadhyay, Kavitha Saravu, Jitendra Singh, Sarman Singh, Mahadev Rao. Microbiome, Immunity, Digestive Health and Nutrition. 2022; : 361 doi: 10.1016/B978-0-12-822238-6.00036-4
77
Na Young Lee, Sang Jun Yoon, Dae Hee Han, Haripriya Gupta, Gi Soo Youn, Min Jea Shin, Young Lim Ham, Min Jung Kwak, Byung Yong Kim, Jeong Seok Yu, Do Yup Lee, Tae-Sik Park, Si-Hyun Park, Byoung Kook Kim, Hyun Chae Joung, In Suk Choi, Ji Taek Hong, Dong Joon Kim, Sang Hak Han, Ki Tae Suk. Lactobacillus and Pediococcus ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome. Gut Microbes 2020; 11(4): 882 doi: 10.1080/19490976.2020.1712984
78
Céline Druart, Maud Alligier, Nuria Salazar, Audrey M. Neyrinck, Nathalie M. Delzenne. Modulation of the Gut Microbiota by Nutrients with Prebiotic and Probiotic Properties. Advances in Nutrition 2014; 5(5): 624S doi: 10.3945/an.114.005835
79
Uday C. Ghoshal, Chalamalasetty Sreenivasa Baba, Ujjala Ghoshal, George Alexander, Asha Misra, Vivek A Saraswat, Gourdas Choudhuri. Low-grade small intestinal bacterial overgrowth is common in patients with non-alcoholic steatohepatitis on quantitative jejunal aspirate culture. Indian Journal of Gastroenterology 2017; 36(5): 390 doi: 10.1007/s12664-017-0797-6
80
Vali Musazadeh, Neda Roshanravan, Parvin Dehghan, Sana Sedgh Ahrabi. Effect of Probiotics on Liver Enzymes in Patients With Non-alcoholic Fatty Liver Disease: An Umbrella of Systematic Review and Meta-Analysis. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.844242
81
David Avelar-Rodríguez, Rubén Peña-Vélez, Jelena Popov, Lee Hill, Paul MacDaragh Ryan. Probiotics and non-alcoholic fatty liver disease in children and adolescents: a systematic review. Revista Española de Enfermedades Digestivas 2022;  doi: 10.17235/reed.2022.8796/2022
82
Nadia Juliana Beraldo Goulart Borges Haubert, Julio Sergio Marchini, Selma Freire Carvalho Cunha, Vivian Marques Miguel Suen, Gilberto Joao Padovan, Alceu Afonso Jordao Junior, Claudia Maria Meirelles Marchini Alves, Julio Flavio Meirelles Marchini, Helio Vannucchi. Choline and Fructooligosaccharide: Non-alcoholic Fatty Liver Disease, Cardiac Fat Deposition, and Oxidative Stress Markers. Nutrition and Metabolic Insights 2015; 8: NMI.S24385 doi: 10.4137/NMI.S24385
83
Brett R Loman, Diego Hernández-Saavedra, Ruopeng An, R Scott Rector. Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Nutrition Reviews 2018; 76(11): 822 doi: 10.1093/nutrit/nuy031
84
Yu. M. Stepanov, I. V. Psareva, O. M. Tatarchuk, E. V. Zygalo, O. P. Petishko. LEVELS OF INTESTINAL INFLAMMATION MARKERS AS A DIAGNOSTIC CRITERION FOR FORMING A RISK GROUP FOR IDENTIFICATION OF SMALL INTESTINAL BACTERIAL OVERGROWTH IN ULCER COLIT . Bulletin of Problems Biology and Medicine 2020; 4(2): 204 doi: 10.29254/2077-4214-2019-4-2-154-204-207
85
Christiane Laue, Ekaterina Papazova, Angelika Pannenbeckers, Jürgen Schrezenmeir. Effect of a Probiotic and a Synbiotic on Body Fat Mass, Body Weight and Traits of Metabolic Syndrome in Individuals with Abdominal Overweight: A Human, Double-Blind, Randomised, Controlled Clinical Study. Nutrients 2023; 15(13): 3039 doi: 10.3390/nu15133039
86
Meysam Zarezadeh, Vali Musazadeh, Amir Hossein Faghfouri, Bahareh Sarmadi, Parsa Jamilian, Parmida Jamilian, Helda Tutunchi, Parvin Dehghan. Probiotic therapy, a novel and efficient adjuvant approach to improve glycemic status: An umbrella meta-analysis. Pharmacological Research 2022; 183: 106397 doi: 10.1016/j.phrs.2022.106397
87
Mehri Jamilian, Elaheh Amirani, Zatollah Asemi. The effects of vitamin D and probiotic co-supplementation on glucose homeostasis, inflammation, oxidative stress and pregnancy outcomes in gestational diabetes: A randomized, double-blind, placebo-controlled trial. Clinical Nutrition 2019; 38(5): 2098 doi: 10.1016/j.clnu.2018.10.028
88
Ahyoung Kim, Arunkumar Krishnan, James P. Hamilton, Tinsay A. Woreta. The Impact of Dietary Patterns and Nutrition in Nonalcoholic Fatty Liver Disease. Gastroenterology Clinics of North America 2021; 50(1): 217 doi: 10.1016/j.gtc.2020.10.013
89
Haripriya Maddur, Brent A Neuschwander-Tetri. More evidence that probiotics may have a role in treating fatty liver disease. The American Journal of Clinical Nutrition 2014; 99(3): 425 doi: 10.3945/ajcn.113.082636
90
Amir Hossein Faghfouri, Ladan Gol Mohammad Pour Afrakoti, Zeynab Kavyani, Zahra Sadeghi Nogourani, Vali Musazadeh, Mahdi Jafarlou, Parvin Dehghan. The role of probiotic supplementation in inflammatory biomarkers in adults: an umbrella meta-analysis of randomized controlled trials. Inflammopharmacology 2023; 31(5): 2253 doi: 10.1007/s10787-023-01332-8
91
Maria Hernandez-Rodas, Rodrigo Valenzuela, Luis Videla. Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2015; 16(10): 25168 doi: 10.3390/ijms161025168
92
Davide Festi, Ramona Schiumerini, Leonardo Henry Eusebi, Giovanni Marasco, Martina Taddia, Antonio Colecchia. Gut microbiota and metabolic syndrome. World Journal of Gastroenterology 2014; 20(43): 16079-16094 doi: 10.3748/wjg.v20.i43.16079
93
Anne-Marie Cassard, Camille Houron, Dragos Ciocan. Microbiote intestinal et stéatopathie métabolique. Nutrition Clinique et Métabolisme 2020; 34(2): 130 doi: 10.1016/j.nupar.2019.12.002
94
Mohammad Mehdi Ommati, Huifeng Li, Akram Jamshidzadeh, Fereshteh Khoshghadam, Socorro Retana-Márquez, Yu Lu, Omid Farshad, Mohammad Hasan Nategh Ahmadi, Ahmad Gholami, Reza Heidari. The crucial role of oxidative stress in non-alcoholic fatty liver disease-induced male reproductive toxicity: the ameliorative effects of Iranian indigenous probiotics. Naunyn-Schmiedeberg's Archives of Pharmacology 2022; 395(2): 247 doi: 10.1007/s00210-021-02177-0
95
IG Saleh, Z Ali, MA Hammad, FD Wilson, FM Hamada, MF Abd-Ellah, LA Walker, IA Khan, MK Ashfaq. Stem cell intervention ameliorates epigallocatechin-3-gallate/lipopolysaccharide-induced hepatotoxicity in mice. Human & Experimental Toxicology 2015; 34(11): 1180 doi: 10.1177/0960327115572707
96
Seyed Mohammad Seifati, Erfan Zaker, Farzaneh Fesahat, Fateme Zare, Seyedhossein Hekmatimoghaddam, Zubeyir Huyut. Modulatory Effect of Probiotics on Proinflammatory Cytokine Levels in Acrylamide-Treated Rats. Biochemistry Research International 2021; 2021: 1 doi: 10.1155/2021/2268770
97
Νikolaos Gkiourtzis, Georgios Kalopitas, Andreas Vadarlis, Dimitra Rafailia Bakaloudi, Georgios Dionysopoulos, Evangelia Karanika, Eirini Tsekitsidi, Michail Chourdakis. The Benefit of Probiotics in Pediatric Nonalcoholic Fatty Liver Disease: A Meta-analysis of Randomized Control Trials. Journal of Pediatric Gastroenterology & Nutrition 2022; 75(3): e31 doi: 10.1097/MPG.0000000000003537
98
M.-Y. Park, S.J. Kim, E.K. Ko, S.-H. Ahn, H. Seo, M.-K. Sung. Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob mice. Journal of Applied Microbiology 2016; 121(3): 800 doi: 10.1111/jam.13158
99
Yosep Ji, Young Mee Chung, Soyoung Park, Dahye Jeong, Bongjoon Kim, Wilhelm Heinrich Holzapfel. Dose-dependent and strain-dependent anti-obesity effects ofLactobacillus sakeiin a diet induced obese murine model. PeerJ 2019; 7: e6651 doi: 10.7717/peerj.6651
100
Sheila Wilhelm, Pramodini Kale-Pradhan. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 20th Edition. 2020;  doi: 10.21019/9781582123172.ch20
101
Grace B. Hatton, Shaolu Ran, Thomas H. Tranah, Debbie L. Shawcross. Lessons Learned from Faecal Microbiota Transplantation in Cirrhosis. Current Hepatology Reports 2020; 19(3): 159 doi: 10.1007/s11901-020-00520-2
102
Omima S. Mohammed, Hany G. Attia, Bassim M. S. A. Mohamed, Marawan A. Elbaset, Hany M. Fayed. Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches. Journal of Pharmacy & Pharmaceutical Sciences 2023; 26 doi: 10.3389/jpps.2023.11808
103
Carolina M. Perdomo, Gema Frühbeck, Javier Escalada. Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease. Nutrients 2019; 11(3): 677 doi: 10.3390/nu11030677
104
Amirhossein Naghipour, Ehsan Amini-Salehi, Mahdi Orang Gorabzarmakhi, Milad Shahdkar, Bahman Fouladi, Iraj Alipourfard, Zahra Momayez Sanat. Effects of gut microbial therapy on lipid profile in individuals with non-alcoholic fatty liver disease: an umbrella meta-analysis study. Systematic Reviews 2023; 12(1) doi: 10.1186/s13643-023-02299-x
105
Alabagi Abdulla, Charity Reynolds, H Hesham A-Kader. Non-Alcoholic Fatty Liver Disease (NAFLD): The Search for a Cure. European Medical Journal 2016; : 93 doi: 10.33590/emj/10314771
106
Nazarii Kobyliak, Ludovico Abenavoli, Tetyana Falalyeyeva, Galyna Mykhalchyshyn, Luigi Boccuto, Liudmyla Kononenko, Dmytro Kyriienko, Iuliia Komisarenko, Oleg Dynnyk. Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical study. Minerva Medica 2018; 109(6) doi: 10.23736/S0026-4806.18.05845-7
107
Carolina M. Perdomo, Nuria Garcia-Fernandez, Javier Escalada. Diabetic Kidney Disease, Cardiovascular Disease and Non-Alcoholic Fatty Liver Disease: A New Triumvirate?. Journal of Clinical Medicine 2021; 10(9): 2040 doi: 10.3390/jcm10092040
108
Song Lin, Shanliang Zhao, Jiahong Liu, Jianwen Zhang, Chao Zhang, Haibo Hao, Yuxia Sun, Jing Cai, Yang Yang, Yan Ma, Yuanyuan Li, Jinyu Wang, Aiguo Ma. Efficacy of proprietary Lactobacillus casei for anti-tuberculosis associated gastrointestinal adverse reactions in adult patients: a randomized, open-label, dose–response trial. Food & Function 2020; 11(1): 370 doi: 10.1039/C9FO01583C
109
Wei Wang, Ai-Lei Xu, Zheng-Chao Li, Yi Li, Shun-Fu Xu, Hua-Chao Sang, Fachao Zhi. Combination of Probiotics and Salvia miltiorrhiza Polysaccharide Alleviates Hepatic Steatosis via Gut Microbiota Modulation and Insulin Resistance Improvement in High Fat-Induced NAFLD Mice. Diabetes & Metabolism Journal 2020; 44(2): 336 doi: 10.4093/dmj.2019.0042
110
Jay Luther, John J. Garber, Hamed Khalili, Maneesh Dave, Shyam Sundhar Bale, Rohit Jindal, Daniel L. Motola, Sanjana Luther, Stefan Bohr, Soung Won Jeoung, Vikram Deshpande, Gurminder Singh, Jerrold R. Turner, Martin L. Yarmush, Raymond T. Chung, Suraj J. Patel. Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability. Cellular and Molecular Gastroenterology and Hepatology 2015; 1(2): 222 doi: 10.1016/j.jcmgh.2015.01.001
111
Emilia Rusu, Georgiana Enache, Raluca Cursaru, Alexandra Alexescu, Raluca Radu, Oana Onila, Teodora Cavallioti, Florin Rusu, Mihaela Posea, Mariana Jinga, Gabriela Radulian. Prebiotics and probiotics in atopic dermatitis (Review) . Experimental and Therapeutic Medicine 2019;  doi: 10.3892/etm.2019.7678
112
Thomas Tu, Magdalena Budzinska, Annette Maczurek, Robert Cheng, Anna Di Bartolomeo, Fiona Warner, Geoffrey McCaughan, Susan McLennan, Nicholas Shackel. Novel Aspects of the Liver Microenvironment in Hepatocellular Carcinoma Pathogenesis and Development. International Journal of Molecular Sciences 2014; 15(6): 9422 doi: 10.3390/ijms15069422
113
Amir Hadi, Hamed Mohammadi, Maryam Miraghajani, Ehsan Ghaedi. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD. Critical Reviews in Food Science and Nutrition 2019; 59(15): 2494 doi: 10.1080/10408398.2018.1458021
114
Ilva Lazda, Angelika Krūmiņa, Indra Zeltiņa, Nikola Krūmiņa, Juris ķibilds, Inese Siksna, Ludmila Vīksna, Aleksejs Derovs. Microbial Community of Kefir and its Impact on the Gastrointestinal Microbiome in Health and Disease. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 2020; 74(2): 58 doi: 10.2478/prolas-2020-0009
115
Giselle S. Escouto, Gabriela Z. Port, Cristiane V. Tovo, Sabrina A. Fernandes, Alessandra Peres, Gilson P. Dorneles, Vanessa P. Houde, Thibault V. Varin, Geneviève Pilon, André Marette, Caroline Buss. Probiotic Supplementation, Hepatic Fibrosis, and the Microbiota Profile in Patients with Nonalcoholic Steatohepatitis: A Randomized Controlled Trial. The Journal of Nutrition 2023; 153(7): 1984 doi: 10.1016/j.tjnut.2023.05.019
116
Sanja Stojsavljević, Marija Gomerčić Palčić, Lucija Virović Jukić, Lea Smirčić Duvnjak, Marko Duvnjak. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2014; 20(48): 18070-18091 doi: 10.3748/wjg.v20.i48.18070
117
Xu Wang, Linlin Shi, Xinping Wang, Yi Feng, Yuan Wang. MDG-1, an Ophiopogon polysaccharide, restrains process of non-alcoholic fatty liver disease via modulating the gut-liver axis. International Journal of Biological Macromolecules 2019; 141: 1013 doi: 10.1016/j.ijbiomac.2019.09.007
118
Tatsuo Kanda, Taichiro Goto, Yosuke Hirotsu, Ryota Masuzaki, Mitsuhiko Moriyama, Masao Omata. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma. International Journal of Molecular Sciences 2020; 21(4): 1525 doi: 10.3390/ijms21041525
119
Claudineia Almeida de SOUZA, Raquel ROCHA, Priscila Ribas de Farias COSTA, Naiade Silveira ALMEIDA, Helma Pinchemel COTRIM. PROBIOTIC, PREBIOTIC OR SYMBIOTIC SUPPLEMENTATION IMPACTS ON INTESTINAL MICROBIOTA IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE: A SYSTEMATIC REVIEW. Arquivos de Gastroenterologia 2022; 59(1): 123 doi: 10.1590/s0004-2803.202200001-21
120
Jessica Tsuei, Thinh Chau, David Mills, Yu-Jui Yvonne Wan. Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer. Experimental Biology and Medicine 2014; 239(11): 1489 doi: 10.1177/1535370214538743
121
Anurag S Lavekar, Dhananjay V Raje, Amarja A Lavekar. Role of Probiotics in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-analysis. Euroasian Journal of Hepato-Gastroenterology 2017; 7(2): 130 doi: 10.5005/jp-journals-10018-1233
122
S Sherf-Dagan, S Zelber-Sagi, G Zilberman-Schapira, M Webb, A Buch, A Keidar, A Raziel, N Sakran, D Goitein, N Goldenberg, J A Mahdi, M Pevsner-Fischer, N Zmora, M Dori-Bachash, E Segal, E Elinav, O Shibolet. Probiotics administration following sleeve gastrectomy surgery: a randomized double-blind trial. International Journal of Obesity 2018; 42(2): 147 doi: 10.1038/ijo.2017.210
123
Jinting Liu, Shuangping Zhen. Protective Effect of Maternal Prebiotics Against Neonatal Jaundice Induced by Phenylhydrazine in Rats. International Journal of Pharmacology 2019; 15(7): 891 doi: 10.3923/ijp.2019.891.899
124
Hyeyoon Eo, You-jin Jeon, Myoungsook Lee, Yunsook Lim. Brown Alga Ecklonia cava Polyphenol Extract Ameliorates Hepatic Lipogenesis, Oxidative Stress, and Inflammation by Activation of AMPK and SIRT1 in High-Fat Diet-Induced Obese Mice. Journal of Agricultural and Food Chemistry 2015; 63(1): 349 doi: 10.1021/jf502830b
125
Manuela G. Neuman, Samuel W. French, Samir Zakhari, Stephen Malnick, Helmut K. Seitz, Lawrence B Cohen, Mikko Salaspuro, Andreea Voinea-Griffin, Andrei Barasch, Irina A. Kirpich, Paul G. Thomes, Laura W. Schrum, Terrence M. Donohue, Kusum K. Kharbanda, Marcus Cruz, Mihai Opris. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage. Experimental and Molecular Pathology 2017; 102(1): 162 doi: 10.1016/j.yexmp.2017.01.003
126
Anne-Marie Cassard, Philippe Gérard, Gabriel Perlemuter. Bugs as Drugs. 2018; : 187 doi: 10.1128/9781555819705.ch8
127
Mariana Machado, Helena Cortez-Pinto. Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet. International Journal of Molecular Sciences 2016; 17(4): 481 doi: 10.3390/ijms17040481
128
Yanjun Cui, Sirui Qi, Wenming Zhang, Jiangdi Mao, Renlong Tang, Chong Wang, Jianxin Liu, Xin M Luo, Haifeng Wang. Lactobacillus reuteri ZJ617 Culture Supernatant Attenuates Acute Liver Injury Induced in Mice by Lipopolysaccharide. The Journal of Nutrition 2019; 149(11): 2046 doi: 10.1093/jn/nxz088
129
Neel Jayesh Shah, Onkar C. Swami. Role of Probiotics in Diabetes: A Review of Their Rationale and Efficacy. EMJ Diabetes 2017; : 104 doi: 10.33590/emjdiabet/10310327
130
Asma Kazemi, Sepideh Soltani, Sima Ghorabi, Abbas Keshtkar, Elnaz Daneshzad, Fatemeh Nasri, Seyed Mohammad Mazloomi. Effect of probiotic and synbiotic supplementation on inflammatory markers in health and disease status: A systematic review and meta-analysis of clinical trials. Clinical Nutrition 2020; 39(3): 789 doi: 10.1016/j.clnu.2019.04.004
131
Maddalena Petraroli, Eleonora Castellone, Viviana Patianna, Susanna Esposito. Gut Microbiota and Obesity in Adults and Children: The State of the Art. Frontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.657020
132
Hamed Ebrahimzadeh Leylabadlo, Reza Ghotaslou, Hossein Samadi Kafil, Mohammad Mehdi Feizabadi, Seyed Yaghoub Moaddab, Safar Farajnia, Elham Sheykhsaran, Sarvin Sanaie, Dariush Shanehbandi, Hossein Bannazadeh Baghi. Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies. European Journal of Clinical Microbiology & Infectious Diseases 2020; 39(4): 613 doi: 10.1007/s10096-019-03746-1
133
Dengfeng Xu, Lingmeng Fu, Da Pan, YiFang Chu, Meiyuan Feng, Yifei Lu, Chao Yang, Yuanyuan Wang, Jiayue Xia, Guiju Sun. Role of probiotics/synbiotic supplementation in glycemic control: A critical umbrella review of meta-analyses of randomized controlled trials. Critical Reviews in Food Science and Nutrition 2024; 64(6): 1467 doi: 10.1080/10408398.2022.2117783
134
Xiao-Fang Yang, Ming Lu, Lijiao You, Huan Gen, Lin Yuan, Tianning Tian, Chun-Yu Li, Kailiang Xu, Jie Hou, Ming Lei. Herbal therapy for ameliorating nonalcoholic fatty liver disease via rebuilding the intestinal microecology. Chinese Medicine 2021; 16(1) doi: 10.1186/s13020-021-00470-x
135
Anne-Marie Cassard, Philippe Gérard, Gabriel Perlemuter, Robert Allen Britton, Patrice D. Cani. Microbiota, Liver Diseases, and Alcohol. Microbiology Spectrum 2017; 5(4) doi: 10.1128/microbiolspec.BAD-0007-2016
136
Soo Lim, Tae Jung Oh, Kwang Kon Koh. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders. International Journal of Cardiology 2015; 201: 408 doi: 10.1016/j.ijcard.2015.08.107
137
Muhammad Safiullah Virk, Muhammad Abdulrehman Virk, Yufeng He, Tabussam Tufail, Mehak Gul, Abdul Qayum, Abdur Rehman, Arif Rashid, John-Nelson Ekumah, Xu Han, Junxia Wang, Xiaofeng Ren. The Anti-Inflammatory and Curative Exponent of Probiotics: A Comprehensive and Authentic Ingredient for the Sustained Functioning of Major Human Organs. Nutrients 2024; 16(4): 546 doi: 10.3390/nu16040546
138
Ivana Milosevic, Ankica Vujovic, Aleksandra Barac, Marina Djelic, Milos Korac, Aleksandra Radovanovic Spurnic, Ivana Gmizic, Olja Stevanovic, Vladimir Djordjevic, Nebojsa Lekic, Edda Russo, Amedeo Amedei. Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature. International Journal of Molecular Sciences 2019; 20(2): 395 doi: 10.3390/ijms20020395
139
Carly E Kelley, Ann J Brown, Anna Mae Diehl, Tracy L Setji. Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome. World Journal of Gastroenterology 2014; 20(39): 14172-14184 doi: 10.3748/wjg.v20.i39.14172
140
Claudia P. Oliveira, Priscila de Lima Sanches, Erlon Oliveira de Abreu-Silva, Aline Marcadenti. Nutrition and Physical Activity in Nonalcoholic Fatty Liver Disease. Journal of Diabetes Research 2016; 2016: 1 doi: 10.1155/2016/4597246
141
Tanya Ralli, Zoya Saifi, Neha Tyagi, Arya Vidyadhari, Vidhu Aeri, Kanchan Kohli. Deciphering the role of gut metabolites in non-alcoholic fatty liver disease. Critical Reviews in Microbiology 2023; 49(6): 815 doi: 10.1080/1040841X.2022.2142091
142
Ayub Ali, Nazrul Islam, Nazrul Islam Fakir, Ahsan Kabir, Mowmita Sharmin, Tazul Islam, Masudur Rahman, Fakrul Amin Badal, Abu Taher. The Science Underlying the Probiotic Strain Bifidobacterium in Beneficial Effects on Immunological and Gastrointestinal Health. International Journal of Immunology 2024; 12(1): 10 doi: 10.11648/j.iji.20241201.12
143
Khadijeh Abhari, Saeede Saadati, Zahra Yari, Hedayat Hosseini, Mehdi Hedayati, Shahabeddin Abhari, Seyyed Moayyed Alavian, Azita Hekmatdoost. The effects of Bacillus coagulans supplementation in patients with non-alcoholic fatty liver disease: A randomized, placebo-controlled, clinical trial. Clinical Nutrition ESPEN 2020; 39: 53 doi: 10.1016/j.clnesp.2020.06.020
144
Sanjoy Roychowdhury, Praveen Selvakumar, Gail Cresci. The Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease. Medical Sciences 2018; 6(2): 47 doi: 10.3390/medsci6020047
145
Jingguo Li, Biguang Tuo, Stefano Gitto. Current and Emerging Approaches for Hepatic Fibrosis Treatment. Gastroenterology Research and Practice 2021; 2021: 1 doi: 10.1155/2021/6612892
146
Natascha Roehlen, Emilie Crouchet, Thomas F. Baumert. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells 2020; 9(4): 875 doi: 10.3390/cells9040875
147
R. Barazzoni, N.E.P. Deutz, G. Biolo, S. Bischoff, Y. Boirie, T. Cederholm, C. Cuerda, N. Delzenne, M. Leon Sanz, O. Ljungqvist, M. Muscaritoli, C. Pichard, J.C. Preiser, P. Sbraccia, P. Singer, L. Tappy, B. Thorens, A. Van Gossum, R. Vettor, P.C. Calder. Carbohydrates and insulin resistance in clinical nutrition: Recommendations from the ESPEN expert group. Clinical Nutrition 2017; 36(2): 355 doi: 10.1016/j.clnu.2016.09.010
148
Wenke Feng, Craig McClain. Molecules, Systems and Signaling in Liver Injury. 2017; : 251 doi: 10.1007/978-3-319-58106-4_11
149
Małgorzata Moszak, Monika Szulińska, Marta Walczak-Gałęzewska, Paweł Bogdański. Nutritional Approach Targeting Gut Microbiota in NAFLD—To Date. International Journal of Environmental Research and Public Health 2021; 18(4): 1616 doi: 10.3390/ijerph18041616
150
Savinda Liyanagedera, Robert Patrick Williams, Silvio Veraldi, Valerio Nobili, Jake P. Mann. The pharmacological management of NAFLD in children and adolescents. Expert Review of Clinical Pharmacology 2017; 10(11): 1225 doi: 10.1080/17512433.2017.1365599
151
T. Vaikunthanathan, N. Safinia, G. Lombardi, R.I. Lechler. Microbiota, immunity and the liver. Immunology Letters 2016; 171: 36 doi: 10.1016/j.imlet.2016.01.008
152
Vishal Singh, Beng San Yeoh, James M. Ntambi, Matam Vijay-Kumar. Hepatic De Novo Lipogenesis and Regulation of Metabolism. 2016; : 189 doi: 10.1007/978-3-319-25065-6_9
153
R. V. Maslennikov, Yu. V. Evsyutina. Non-Alcoholic Fatty Liver Disease, Bile Acids and Intestinal Microbiota. Rossijskij žurnal gastroènterologii gepatologii koloproktologii 2018; 28(4): 84 doi: 10.22416/1382-4376-2018-28-4-84-90
154
Laura Baselga-Escudero, Vanessa Souza-Mello, Aïda Pascual-Serrano, Tamiris Rachid, Adriana Voci, Ilaria Demori, Elena Grasselli. Beneficial effects of the Mediterranean spices and aromas on non-alcoholic fatty liver disease. Trends in Food Science & Technology 2017; 61: 141 doi: 10.1016/j.tifs.2016.11.019
155
Nazarii Kobyliak, Caterina Conte, Giovanni Cammarota, Andreana P. Haley, Igor Styriak, Ludovit Gaspar, Jozef Fusek, Luis Rodrigo, Peter Kruzliak. Probiotics in prevention and treatment of obesity: a critical view. Nutrition & Metabolism 2016; 13(1) doi: 10.1186/s12986-016-0067-0
156
Natalia Vallianou, Gerasimos Socrates Christodoulatos, Irene Karampela, Dimitrios Tsilingiris, Faidon Magkos, Theodora Stratigou, Dimitris Kounatidis, Maria Dalamaga. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives. Biomolecules 2021; 12(1): 56 doi: 10.3390/biom12010056
157
Luisa Bonsembiante, Giovanni Targher, Claudio Maffeis. Non-alcoholic fatty liver disease in obese children and adolescents: a role for nutrition?. European Journal of Clinical Nutrition 2022; 76(1): 28 doi: 10.1038/s41430-021-00928-z
158
Abdel-Naser Elzouki. Probiotics and Liver Disease. Journal of Clinical Gastroenterology 2016; 50(Supplement 2): S188 doi: 10.1097/MCG.0000000000000712
159
Alireza Milajerdi, Seyyed Mohammad Mousavi, Alireza Sadeghi, Asma Salari-Moghaddam, Mohammad Parohan, Bagher Larijani, Ahmad Esmaillzadeh. The effect of probiotics on inflammatory biomarkers: a meta-analysis of randomized clinical trials. European Journal of Nutrition 2020; 59(2): 633 doi: 10.1007/s00394-019-01931-8
160
Silvia M. Ferolla, Cláudia A. Couto, Maria de Lourdes A. Ferrari, Luciana Costa Faria, Murilo Pereira, Teresa C.A. Ferrari. Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications. 2019; : 265 doi: 10.1016/B978-0-12-815249-2.00027-0
161
Fuxi Li, Junzhao Ye, Congxiang Shao, Bihui Zhong. Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis. Lipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01440-w
162
Suzanne E. Mahady, Jacob George. Exercise and diet in the management of nonalcoholic fatty liver disease. Metabolism 2016; 65(8): 1172 doi: 10.1016/j.metabol.2015.10.032
163
Laura Marino, François R Jornayvaz. Endocrine causes of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2015; 21(39): 11053-11076 doi: 10.3748/wjg.v21.i39.11053
164
Cosmas Rinaldi A. Lesmana, Maria S. Paramitha, Irsan Hasan. Comprehensive Gut Microbiota. 2022; : 475 doi: 10.1016/B978-0-12-819265-8.00079-6
165
J. Pang, W. Xu, X. Zhang, G. L.‐H. Wong, A. W.‐H. Chan, H.‐Y. Chan, C.‐H. Tse, S. S.‐T. Shu, P. C.‐L. Choi, H. L.‐Y. Chan, J. Yu, V. W.‐S. Wong. Significant positive association of endotoxemia with histological severity in 237 patients with non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 2017; 46(2): 175 doi: 10.1111/apt.14119
166
Matthew T. Goodus, Dana M. McTigue. Hepatic dysfunction after spinal cord injury: A vicious cycle of central and peripheral pathology?. Experimental Neurology 2020; 325: 113160 doi: 10.1016/j.expneurol.2019.113160
167
Fouad M. F. Elshaghabee, Namita Rokana, Harsh Panwar, Knut J. Heller, Jürgen Schrezenmeir. Probiotics for dietary management of non-alcoholic fatty liver disease. Environmental Chemistry Letters 2019; 17(4): 1553 doi: 10.1007/s10311-019-00896-8
168
Jia Wang, Yanfei Hao, Xiao Jin, Xiaoyue Li, Yi Liu, Li Zhang, Jing Wang, Mingxin Hu, Shimin Wang. Health Effects of Probiotics on Nonalcoholic Fatty Liver in the Life Cycle Based on Data Analysis. Computational and Mathematical Methods in Medicine 2022; 2022: 1 doi: 10.1155/2022/2123162
169
Ramesh C. Chandan, Akanksha Gandhi, Nagendra P. Shah. Yogurt in Health and Disease Prevention. 2017; : 3 doi: 10.1016/B978-0-12-805134-4.00001-8
170
Emidio Scarpellini, Sharmila Fagoonee, Emanuele Rinninella, Carlo Rasetti, Isabella Aquila, Tiziana Larussa, Pietrantonio Ricci, Francesco Luzza, Ludovico Abenavoli. Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic. Journal of Clinical Medicine 2020; 9(8): 2488 doi: 10.3390/jcm9082488
171
Meng-Wei Xiao, Shi-Xin Lin, Zhao-Hua Shen, Wei-Wei Luo, Xiao-Yan Wang. Systematic Review with Meta-Analysis: The Effects of Probiotics in Nonalcoholic Fatty Liver Disease. Gastroenterology Research and Practice 2019; 2019: 1 doi: 10.1155/2019/1484598
172
Seyed Ali Jazayeri-Tehrani, Seyed Mahdi Rezayat, Siavash Mansouri, Mostafa Qorbani, Seyed Moayed Alavian, Milad Daneshi-Maskooni, Mohammad-Javad Hosseinzadeh-Attar. Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol. BMJ Open 2017; 7(7): e016914 doi: 10.1136/bmjopen-2017-016914
173
Binbin Zhang, Jie Li, Jinlong Fu, Li Shao, Luping Yang, Junping Shi. Interaction between mucus layer and gut microbiota in non-alcoholic fatty liver disease: Soil and seeds. Chinese Medical Journal 2023; 136(12): 1390 doi: 10.1097/CM9.0000000000002711
174
Jichun Zhao, Fengwei Tian, Nan Zhao, Qixiao Zhai, Hao Zhang, Wei Chen. Effects of probiotics on d -galactose-induced oxidative stress in plasma: A meta-analysis of animal models. Journal of Functional Foods 2017; 39: 44 doi: 10.1016/j.jff.2017.09.055
175
Meysam Zarezadeh, Vali Musazadeh, Amir Hossein Faghfouri, Neda Roshanravan, Parvin Dehghan. Probiotics act as a potent intervention in improving lipid profile: An umbrella systematic review and meta-analysis. Critical Reviews in Food Science and Nutrition 2023; 63(2): 145 doi: 10.1080/10408398.2021.2004578
176
Robert S. Lo, Andrew S. Austin, Jan G. Freeman. Is There a Role for Probiotics in Liver Disease?. The Scientific World Journal 2014; 2014: 1 doi: 10.1155/2014/874768
177
H. Jin, X. Xu, B. Pang, R. Yang, H. Sun, C. Jiang, D. Shao, J. Shi. Probiotic and prebiotic interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysis. Beneficial Microbes 2021; 12(6): 517 doi: 10.3920/BM2020.0183
178
Mohamad Hizami Mohamad Nor, Nurainina Ayob, Norfilza M. Mokhtar, Raja Affendi Raja Ali, Geok Chin Tan, Zhiqin Wong, Nor Hamizah Shafiee, Yin Ping Wong, Muaatamarulain Mustangin, Khairul Najmi Muhammad Nawawi. The Effect of Probiotics (MCP® BCMC® Strains) on Hepatic Steatosis, Small Intestinal Mucosal Immune Function, and Intestinal Barrier in Patients with Non-Alcoholic Fatty Liver Disease. Nutrients 2021; 13(9): 3192 doi: 10.3390/nu13093192
179
Silke Crommen, Karl Peter Rheinwalt, Andreas Plamper, Marie-Christine Simon, Daniela Rösler, Rolf Fimmers, Sarah Egert, Christine Metzner. A Specifically Tailored Multistrain Probiotic and Micronutrient Mixture Affects Nonalcoholic Fatty Liver Disease—Related Markers in Patients with Obesity after Mini Gastric Bypass Surgery. The Journal of Nutrition 2022; 152(2): 408 doi: 10.1093/jn/nxab392
180
Jin Imai, Sho Kitamoto, Nobuhiko Kamada. The pathogenic oral–gut–liver axis: new understandings and clinical implications. Expert Review of Clinical Immunology 2021; 17(7): 727 doi: 10.1080/1744666X.2021.1935877
181
Michael Doulberis, Georgios Kotronis, Dimitra Gialamprinou, Jannis Kountouras, Panagiotis Katsinelos. Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota. Metabolism 2017; 71: 182 doi: 10.1016/j.metabol.2017.03.013
182
Norberto C. Chávez-Tapia, Leticia González-Rodríguez, MinSeung Jeong, Yanine López-Ramírez, Varenka Barbero-Becerra, Eva Juárez-Hernández, Juan L. Romero-Flores, Marco Arrese, Nahúm Méndez-Sánchez, Misael Uribe. Current evidence on the use of probiotics in liver diseases. Journal of Functional Foods 2015; 17: 137 doi: 10.1016/j.jff.2015.05.009
183
Ahmed M. El-Baz, Amira M. El-Ganiny, Doaa Hellal, Hala M. Anwer, Hend A. Abd El-Aziz, Ibrahim E. Tharwat, Mohamed A. El-Adawy, Shehab El-Din M. Helal, Menna Tallah A. Mohamed, Tassnim M. Azb, Hanya M. Elshafaey, AbdulRahman A. Shalata, Sahar M. Elmeligi, Noran H. Abdelbary, Attalla F. El-kott, Fatimah A. Al-Saeed, Eman T. Salem, Mohamed M. Adel El-Sokkary, Ahmed Shata, Ahmed A. Shabaan. Valuable effects of lactobacillus and citicoline on steatohepatitis: role of Nrf2/HO-1 and gut microbiota. AMB Express 2023; 13(1) doi: 10.1186/s13568-023-01561-8
184
Bobae Kim, Jeonghyeon Kwon, Min-Seok Kim, Haryung Park, Yosep Ji, Wilhelm Holzapfel, Chang-Kee Hyun, Marcia B. Aguila. Protective effects of Bacillus probiotics against high-fat diet-induced metabolic disorders in mice. PLOS ONE 2018; 13(12): e0210120 doi: 10.1371/journal.pone.0210120
185
Leila Javadi, Mostafa Ghavami, Manouchehr Khoshbaten, Abdolrasoul Safaiyan, Abolfazl Barzegari, Bahram Pourghassem Gargari. The Effect of Probiotic and/or Prebiotic on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease: A Double Blind Randomized Clinical Trial. Iranian Red Crescent Medical Journal 2017; 19(4) doi: 10.5812/ircmj.46017
186
E. B. Mitchel, J. E. Lavine. Review article: the management of paediatric nonalcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 2014; 40(10): 1155 doi: 10.1111/apt.12972
187
Natalia Nuño-Lámbarri, Norberto C. Chávez-Tapia, Misael Uribe. Encyclopedia of Food Chemistry. 2019; : 387 doi: 10.1016/B978-0-08-100596-5.21759-9
188
Pietro Vajro, Marco Poeta, Luca Pierri, Cristina Pizza, Roberta D’Aniello, Maria Sangermano, Grazia Massa, Giulia Paolella. Nutrition in the Prevention and Treatment of Abdominal Obesity. 2014; : 363 doi: 10.1016/B978-0-12-407869-7.00033-7
189
Julian R Marchesi, David H Adams, Francesca Fava, Gerben D A Hermes, Gideon M Hirschfield, Georgina Hold, Mohammed Nabil Quraishi, James Kinross, Hauke Smidt, Kieran M Tuohy, Linda V Thomas, Erwin G Zoetendal, Ailsa Hart. The gut microbiota and host health: a new clinical frontier. Gut 2016; 65(2): 330 doi: 10.1136/gutjnl-2015-309990
190
Gregor Lorbek, Žiga Urlep, Damjana Rozman. Pharmacogenomic and personalized approaches to tackle nonalcoholic fatty liver disease. Pharmacogenomics 2016; 17(11): 1273 doi: 10.2217/pgs-2016-0047
191
Mehran Rahimlou, Hoda Ahmadnia, Azita Hekmatdoost. Dietary supplements and pediatric non-alcoholic fatty liver disease: Present and the future. World Journal of Hepatology 2015; 7(25): 2597-2602 doi: 10.4254/wjh.v7.i25.2597
192
Angelica Carreira dos Santos, Daniel Araki Ribeiro, Jessica Almeida da Cruz Ferreira, Odair Aguiar, Dan Linetzky Waitzberg, Claudia Cristina Alves. Inflammatory gene expression analysis after prebiotic, probiotic and synbiotic supplementation in experimental nonalcoholic fatty liver disease. Nutrition & Food Science 2019; 49(1): 75 doi: 10.1108/NFS-04-2018-0119
193
Tetyana FALALYEYEVA, Yelyzaveta MAMULA, Emidio SCARPELLINI, Ivan LESHCHENKO, Alla HUMENIUK, Ivan PANKIV, Nazarii KOBYLIAK. Probiotics and obesity associated disease: an extended view beyond traditional strains. Minerva Gastroenterology 2022; 67(4) doi: 10.23736/S2724-5985.21.02909-0
194
Silvia M. Ferolla. Obesity. 2016; : 159 doi: 10.1007/978-3-319-19821-7_13
195
Sang Hak Han, Ki Tae Suk, Dong Joon Kim, Moon Young Kim, Soon Koo Baik, Young Don Kim, Gab Jin Cheon, Dae Hee Choi, Young Lim Ham, Dong Hoon Shin, Eun Ji Kim. Effects of probiotics (cultured Lactobacillus subtilis/Streptococcus faecium) in the treatment of alcoholic hepatitis. European Journal of Gastroenterology & Hepatology 2015; 27(11): 1300 doi: 10.1097/MEG.0000000000000458
196
Lucio Capurso. Thirty Years of Lactobacillus rhamnosus GG. Journal of Clinical Gastroenterology 2019; 53(Supplement 1): S1 doi: 10.1097/MCG.0000000000001170
197
So Yeong Cheon, Juhyun Song. Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation. Cell & Bioscience 2022; 12(1) doi: 10.1186/s13578-022-00836-0
198
Ahad Eshraghian. Current and emerging pharmacological therapy for non-alcoholic fatty liver disease. World Journal of Gastroenterology 2017; 23(42): 7495-7504 doi: 10.3748/wjg.v23.i42.7495
199
K A Aitbaev, I T Murkamilov, V V Fomin. Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulation. Terapevticheskii arkhiv 2017; 89(8): 120 doi: 10.17116/terarkh2017898120-128
200
Salman Shirvani-Rad, Ozra Tabatabaei-Malazy, Shahrzad Mohseni, Shirin Hasani-Ranjbar, Ahmad-Reza Soroush, Zahra Hoseini-Tavassol, Hanieh-Sadat Ejtahed, Bagher Larijani, Vincenzo De Feo. Probiotics as a Complementary Therapy for Management of Obesity: A Systematic Review. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/6688450
201
Suzanne R Sharpton, Bharat Maraj, Emily Harding-Theobald, Eric Vittinghoff, Norah A Terrault. Gut microbiome–targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression. The American Journal of Clinical Nutrition 2019; 110(1): 139 doi: 10.1093/ajcn/nqz042
202
Jennifer E. Lambert, Jill A. Parnell, Bertus Eksteen, Maitreyi Raman, Marc R. Bomhof, Kevin P. Rioux, Karen L. Madsen, Raylene A. Reimer. Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol. BMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0400-5
203
Felipe Galvão Batista Chaves, Glauco Ferreira de Oliveira, João Paulo Ribeiro, João Victor Serafim, Luiz Felipe Medeiros Cordeiro, Matheus Alves Alvares, Marcelo Trindade Cecchi, Murilo Cordeiro Vasquez, Thaísy Bianka Dorta de Souza, Vera Esteves Vagnozzi Rullo. THE THERAPEUTIC IMPACT OF PROBIOTICS ON NONALCOHOLIC FATTY LIVER DISEASE IN PEDIATRICS: A SYSTEMATIC REVIEW. Revista Paulista de Pediatria 2021; 39 doi: 10.1590/1984-0462/2021/39/2019226
204
Yolanda Sánchez-Torrijos, Leticia Álvarez-Amor, Rocío Aller, Pedro Pablo García-Luna, Franz Martín, Manuel Romero-Gómez. Non-Alcoholic Fatty Liver Disease. 2020; : 271 doi: 10.1007/978-3-319-95828-6_15
205
Vali Musazadeh, Meysam Zarezadeh, Faezeh Ghalichi, Sana Sedgh Ahrabi, Parmida Jamilian, Parsa Jamilian, Zohreh Ghoreishi. Anti-obesity properties of probiotics; a considerable medical nutrition intervention: Findings from an umbrella meta-analysis. European Journal of Pharmacology 2022; 928: 175069 doi: 10.1016/j.ejphar.2022.175069
206
Jasmohan S. Bajaj, Alexander Khoruts. Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis. Journal of Hepatology 2020; 72(5): 1003 doi: 10.1016/j.jhep.2020.01.017
207
Nicola Humphry. Updates in the Role of Pre- and Probiotics in Health and Disease: Where Do We Stand Today?. EMJ Gastroenterology 2022; : 4 doi: 10.33590/emjgastroenterol/10075567
208
Myungsuk Kim, Young Gyun Park, Hee-Ju Lee, Sue Ji Lim, Hong Ryul Ahn, Sang Hoon Jung, Chu Won Nho. Youngia denticulata attenuates diet-induced obesity-related metabolic dysfunctions by activating AMP-activated protein kinase and regulating lipid metabolism. Journal of Functional Foods 2015; 18: 714 doi: 10.1016/j.jff.2015.09.002
209
Angela Horvath, Bettina Leber, Nicole Feldbacher, Markus Steinwender, Irina Komarova, Florian Rainer, Andreas Blesl, Vanessa Stadlbauer. The effects of a multispecies synbiotic on microbiome-related side effects of long-term proton pump inhibitor use: A pilot study. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59550-x
210
Hassan M. Heshmati. Advances in Hepatology. 2021;  doi: 10.5772/intechopen.97568
211
Juliana Paula Bruch-Bertani, Carolina Uribe-Cruz, Amanda Pasqualotto, Larisse Longo, Raquel Ayres, Carolina Bortolin Beskow, Afonso Luis Barth, Daiana Lima-Morales, Fábio Meurer, Gabriel Tayguara Silveira Guerreiro, Themis Reverbel da Silveira, Mário Reis Álvares-da-Silva, Valesca Dall’Alba. Hepatoprotective Effect of Probiotic Lactobacillus rhamnosus GG Through the Modulation of Gut Permeability and Inflammasomes in a Model of Alcoholic Liver Disease in Zebrafish. Journal of the American College of Nutrition 2020; 39(2): 163 doi: 10.1080/07315724.2019.1627955
212
Effects of probiotics combined with dietary and lifestyle modification on clinical, biochemical, and radiological parameters in obese children with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: a randomized clinical trial. Clinical and Experimental Pediatrics 2022; 65(6): 304 doi: 10.3345/cep.2021.00787
213
Kazunari Kadokura, Tsuyoshi Tomita, Kohei Suruga. Effect of fish paste products, fish balls ‘tsumire’, intake in Sprague–Dawley rats. Journal of Nutritional Science 2021; 10 doi: 10.1017/jns.2021.57
214
Abinash Mahapatro, Fnu Bawna, Vikash Kumar, Amir Ali Daryagasht, Siddharth Gupta, Nakka Raghuma, Saman Soltani Moghdam, Akshita Kolla, Shruti Sagar Mahapatra, Nazila Sattari, Ehsan Amini-Salehi, Sandeep S. Nayak. Anti-inflammatory effects of probiotics and synbiotics on patients with non-alcoholic fatty liver disease: An umbrella study on meta-analyses. Clinical Nutrition ESPEN 2023; 57: 475 doi: 10.1016/j.clnesp.2023.07.087
215
Reenam S. Khan, Fernando Bril, Kenneth Cusi, Philip N. Newsome. Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease. Hepatology 2019; 70(2): 711 doi: 10.1002/hep.30429
216
Marco Toscano, Roberta De Grandi, Luca Pastorelli, Maurizio Vecchi, Lorenzo Drago. A consumer’s guide for probiotics: 10 golden rules for a correct use. Digestive and Liver Disease 2017; 49(11): 1177 doi: 10.1016/j.dld.2017.07.011
217
Saba Mohammadi, Fatemeh Rostamkhani, Shahin Riyahi Malayeri, Hossein Shirvani. High-intensity interval training with probiotic supplementation decreases gene expression of NF-κβ and CXCL2 in small intestine of rats with steatosis. Sport Sciences for Health 2022; 18(2): 491 doi: 10.1007/s11332-021-00829-5
218
Bobae Kim, Kun-Young Park, Yosep Ji, Soyoung Park, Wilhelm Holzapfel, Chang-Kee Hyun. Protective effects of Lactobacillus rhamnosus GG against dyslipidemia in high-fat diet-induced obese mice. Biochemical and Biophysical Research Communications 2016; 473(2): 530 doi: 10.1016/j.bbrc.2016.03.107
219
Gaeun Kim, Soon Koo Baik. Overview and recent trends of systematic reviews and meta-analyses in hepatology. Clinical and Molecular Hepatology 2014; 20(2): 137 doi: 10.3350/cmh.2014.20.2.137
220
Nearmeen M. Rashad, Amal S. El-Shal, Abdelaziz I. Amin, Manar H. Soliman. Effects of probiotics supplementation on macrophage migration inhibitory factor and clinical laboratory feature of polycystic ovary syndrome. Journal of Functional Foods 2017; 36: 317 doi: 10.1016/j.jff.2017.06.029
221
Rossella Palma, Annamaria Pronio, Mario Romeo, Flavia Scognamiglio, Lorenzo Ventriglia, Vittorio Maria Ormando, Antonietta Lamazza, Stefano Pontone, Alessandro Federico, Marcello Dallio. The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications. Journal of Clinical Medicine 2022; 11(13): 3649 doi: 10.3390/jcm11133649
222
Xiaolin Gao, Yu Zhu, Yang Wen, Guanjian Liu, Chaomin Wan. Efficacy of probiotics in non‐alcoholic fatty liver disease in adult and children: A meta‐analysis of randomized controlled trials. Hepatology Research 2016; 46(12): 1226 doi: 10.1111/hepr.12671
223
Ehsan Amini-Salehi, Soheil Hassanipour, Mohammad-Hossein Keivanlou, Milad Shahdkar, Mahdi Orang Goorabzarmakhi, Azin Vakilpour, Farahnaz Joukar, Mohammad Hashemi, Nazila Sattari, Mohammadreza Javid, Fariborz Mansour-Ghanaei. The impact of gut microbiome-targeted therapy on liver enzymes in patients with nonalcoholic fatty liver disease: an umbrella meta-analysis. Nutrition Reviews 2023;  doi: 10.1093/nutrit/nuad086
224
Fredrik Rosqvist, Andreas Rydell, David Iggman. The Effects of Foods on Blood Lipids in Non-alcoholic Fatty Liver Disease (NAFLD)—A Systematic Review and Meta-Analysis. Frontiers in Nutrition 2020; 7 doi: 10.3389/fnut.2020.613221
225
Hessah Mohammed Al-muzafar, Kamal Adel Amin. Probiotic mixture improves fatty liver disease by virtue of its action on lipid profiles, leptin, and inflammatory biomarkers. BMC Complementary and Alternative Medicine 2017; 17(1) doi: 10.1186/s12906-016-1540-z
226
Simona Cernea, Danusia Onișor. Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma. World Journal of Gastroenterology 2023; 29(2): 286-309 doi: 10.3748/wjg.v29.i2.286
227
Luis Vitetta, Sean Hall, Samantha Coulson. Metabolic Interactions in the Gastrointestinal Tract (GIT): Host, Commensal, Probiotics, and Bacteriophage Influences. Microorganisms 2015; 3(4): 913 doi: 10.3390/microorganisms3040913
228
Lu-Lu Gao, Yu-Xiang Li, Jia-Min Ma, Yi-Qiong Guo, Lin Li, Qing-Han Gao, Yan-Na Fan, Meng-Wei Zhang, Xiu-Juan Tao, Jian-Qiang Yu, Jian-Jun Yang. Effect of Lycium barbarum polysaccharide supplementation in non-alcoholic fatty liver disease patients: study protocol for a randomized controlled trial. Trials 2021; 22(1) doi: 10.1186/s13063-021-05529-6
229
Jin-Chul Kim, Joo-Yeong Jeon, Woong-suk Yang, Cheorl-Ho Kim, Dae-Woon Eom. Combined Amelioration of Ginsenoside (Rg1, Rb1, and Rg3)-enriched Korean Red Ginseng and Probiotic Lactobacillus on Non-alcoholic Fatty Liver Disease. Current Pharmaceutical Biotechnology 2019; 20(3): 222 doi: 10.2174/1389201020666190311143554
230
Allyson Dailey, Gloria Solano-Aguilar, Joseph F. Urban, Robin D. Couch. LC-QToF-Based Metabolomics Identifies Aberrant Tissue Metabolites Associated with a Higher-Fat Diet and Their ‘Reversion to Healthy’ with Dietary Probiotic Supplementation. Metabolites 2023; 13(3): 358 doi: 10.3390/metabo13030358
231
Nwe Ni Than, Philip N. Newsome. A concise review of non-alcoholic fatty liver disease. Atherosclerosis 2015; 239(1): 192 doi: 10.1016/j.atherosclerosis.2015.01.001
232
Stephan C. Bischoff, Rocco Barazzoni, Luca Busetto, Marjo Campmans‐Kuijpers, Vincenzo Cardinale, Irit Chermesh, Ahad Eshraghian, Haluk Tarik Kani, Wafaa Khannoussi, Laurence Lacaze, Miguel Léon‐Sanz, Juan M. Mendive, Michael W. Müller, Johann Ockenga, Frank Tacke, Anders Thorell, Darija Vranesic Bender, Arved Weimann, Cristina Cuerda. European guideline on obesity care in patients with gastrointestinal and liver diseases – Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline. United European Gastroenterology Journal 2022; 10(7): 663 doi: 10.1002/ueg2.12280
233
Christopher Irwin, Saman Khalesi, Amanda J. Cox, Gary Grant, Andrew K. Davey, Andrew C. Bulmer, Ben Desbrow. Effect of 8-weeks prebiotics/probiotics supplementation on alcohol metabolism and blood biomarkers of healthy adults: a pilot study. European Journal of Nutrition 2018; 57(4): 1523 doi: 10.1007/s00394-017-1437-8
234
Parth J Parekh, Luis A Balart, David A Johnson. The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease. Clinical and Translational Gastroenterology 2015; 6(6): e91 doi: 10.1038/ctg.2015.16
235
Akriti Shrestha, Sarah Katherine Dellett, Junhui Yang, Upasna Sharma, Latha Ramalingam. Effects of Fish Oil Supplementation on Reducing the Effects of Paternal Obesity and Preventing Fatty Liver in Offspring. Nutrients 2023; 15(24): 5038 doi: 10.3390/nu15245038
236
Yu. M. Stepanov, N. V. Chaliy. INFLUENCE OF SMALL INTESTINAL BACTERIAL OVERGROWTH ON THE COMPLICATIONS OF PORTAL HYPERTENSION IN ITS VARIOUS FORMS . Bulletin of Problems Biology and Medicine 2018; (144): 195 doi: 10.29254/2077-4214-2018-1-2-143-195-198
237
Silvia Marinho Ferolla, Geyza Nogueira de Almeida Armiliato, Cláudia Alves Couto, Teresa Cristina Abreu Ferrari. Probiotics as a complementary therapeutic approach in nonalcoholic fatty liver disease. World Journal of Hepatology 2015; 7(3): 559-565 doi: 10.4254/wjh.v7.i3.559
238
Asieh Mansour, Azita Hekmatdoost, Parvin Mirmiran. What are the main areas of focus to prevent or treat non‐alcoholic fatty liver disease?. Journal of Digestive Diseases 2019; 20(6): 271 doi: 10.1111/1751-2980.12751
239
Anna Jeznach-Steinhagen, Joanna Ostrowska, Aneta Czerwonogrodzka-Senczyna, Iwona Boniecka, Urszula Shahnazaryan, Alina Kuryłowicz. Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease. Medicina 2019; 55(5): 166 doi: 10.3390/medicina55050166
240
Yasuhiko Sawada, Hideto Kawaratani, Takuya Kubo, Yukihisa Fujinaga, Masanori Furukawa, Soichiro Saikawa, Shinya Sato, Kenichiro Seki, Hiroaki Takaya, Yasushi Okura, Kosuke Kaji, Naotaka Shimozato, Tsuyoshi Mashitani, Mitsuteru Kitade, Kei Moriya, Tadashi Namisaki, Takemi Akahane, Akira Mitoro, Junichi Yamao, Hitoshi Yoshiji. Combining probiotics and an angiotensin‐II type 1 receptor blocker has beneficial effects on hepatic fibrogenesis in a rat model of non‐alcoholic steatohepatitis. Hepatology Research 2019; 49(3): 284 doi: 10.1111/hepr.13281
241
Somayyeh Firouzi, Barakatun-Nisak Mohd-Yusof, Hazreen-Abd Majid, Amin Ismail, Nor-Azmi Kamaruddin. Effect of microbial cell preparation on renal profile and liver function among type 2 diabetics: a randomized controlled trial. BMC Complementary and Alternative Medicine 2015; 15(1) doi: 10.1186/s12906-015-0952-5
242
Qingqing Zhang, Yucheng Wu, Xiaoqiang Fei. Effect of probiotics on glucose metabolism in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials. Medicina 2016; 52(1): 28 doi: 10.1016/j.medici.2015.11.008
243
Paraskevas Gkolfakis, George Dimitriadis, Konstantinos Triantafyllou. Gut microbiota and non-alcoholic fatty liver disease. Hepatobiliary & Pancreatic Diseases International 2015; 14(6): 572 doi: 10.1016/S1499-3872(15)60026-1
244
Naga S. Betrapally, Patrick M. Gillevet, Jasmohan S. Bajaj. Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects?. Gastroenterology 2016; 150(8): 1745 doi: 10.1053/j.gastro.2016.02.073
245
Karolina Drożdż, Katarzyna Nabrdalik, Weronika Hajzler, Hanna Kwiendacz, Janusz Gumprecht, Gregory Y. H. Lip. Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota. Nutrients 2021; 14(1): 103 doi: 10.3390/nu14010103
246
Irina A. Kirpich, Luis S. Marsano, Craig J. McClain. Gut–liver axis, nutrition, and non-alcoholic fatty liver disease. Clinical Biochemistry 2015; 48(13-14): 923 doi: 10.1016/j.clinbiochem.2015.06.023
247
Jerome Boursier, Anna Mae Diehl. Nonalcoholic Fatty Liver Disease and the Gut Microbiome. Clinics in Liver Disease 2016; 20(2): 263 doi: 10.1016/j.cld.2015.10.012
248
Barry A. Mizock. Probiotics. Disease-a-Month 2015; 61(7): 259 doi: 10.1016/j.disamonth.2015.03.011
249
Marica Meroni, Miriam Longo, Paola Dongiovanni. The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies. Nutrients 2019; 11(11): 2642 doi: 10.3390/nu11112642
250
Maurizio Koch. Gut Microbiota and the Liver. Journal of Clinical Gastroenterology 2016; 50(Supplement 2): S183 doi: 10.1097/MCG.0000000000000699
251
S. Gitto, G. Vitale, E. Villa, P. Andreone. Treatment of Nonalcoholic Steatohepatitis in Adults: Present and Future. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/732870
252
Qinglan Xia, Yumeng Lei, Jiadun Wang, Qiang Wang. Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis. Open Life Sciences 2023; 18(1) doi: 10.1515/biol-2022-0741
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345